Product Information
CEFTAZIDIME 1 GM VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $3.7045 per EA under NDC 25021012720. Its NADAC has been published 184 times since Jan 22, 2014.
Strength
1 g/1
Manufacturer
Sagent PharmaceuticalsNDC
25021012720
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
12/17/2025
Active Ingredients
CEFTAZIDIMEApproval Type
Generic (ANDA)
FDA Application
ANDA062640On Market Since
5/15/2008
Pharmacological Classes
Price Statistics
The NADAC for CEFTAZIDIME 1 GM VIAL has been published 184 times since Jan 22, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7045 per EA |
|---|---|
| All-time high | $3.8622 (Oct 15, 2025) |
| All-time low | $3.7045 (Oct 22, 2025) |
| 52-week high | $3.8622 |
| 52-week low | $3.7045 |
| Median price | $3.7508 |
| Average price | $3.7649 |
| Largest weekly change | -4.1% (Oct 22, 2025) |
| Weeks tracked | 184 |
| Tracking since | Jan 22, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ceftazidime market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CEFTAZIDIME 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTAZIDIME 1 GM VIAL, manufactured by Sagent Pharmaceuticals, is $3.7045 per EA (NDC 25021012720), effective Jun 24, 2026.
How has the price of CEFTAZIDIME 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFTAZIDIME 1 GM VIAL has held within roughly two percent of its current level. It has been tracked across 184 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CEFTAZIDIME 1 GM VIAL?
Since Jan 22, 2014, the NADAC for CEFTAZIDIME 1 GM VIAL has ranged from a low of $3.7045 (Oct 22, 2025) to a high of $3.8622 (Oct 15, 2025), with a median of $3.7508 per EA.
Are there cheaper alternatives to CEFTAZIDIME 1 GM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CEFTAZIDIME 1 GM VIAL, so no direct lower-cost alternative is listed.
Who manufactures CEFTAZIDIME 1 GM VIAL?
CEFTAZIDIME 1 GM VIAL (NDC 25021012720) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification